NBF-29667-75596
2 vaccinations
0 coded responses
16 check-ins
0 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 05-11
- ZIP prefix
- 983 / WA
- Registered
- 2021-11-09
- Relationship
- Child or adolescent in my care
- Guardian
- EZB-17810-81192
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-09
Registered in v-safe
-
2021-11-09
Dose 1 — Pfizer-BioNTech
-
2021-11-09
Health check-in — day 0, dose 1, dependentFeeling: Poor · Headache, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-11-10
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Fair · Nausea, Abdominal pain · Be unable to work or attend schoolAdult check-in
-
2021-11-11
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Poor · Headache, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-11-12
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Fair · Headache, Nausea, Abdominal pain · Be unable to work or attend schoolAdult check-in
-
2021-11-13
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Fair · Fatigue or tiredness, Nausea, Abdominal painAdult check-in
- 2021-11-14
-
2021-11-15
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Fatigue or tirednessAdult check-in
- 2021-11-18
- 2021-11-23
- 2021-11-30
-
2021-12-03
Dose 2 — Pfizer-BioNTech
- 2021-12-21
- 2021-12-24
- 2021-12-31
- 2022-01-07
- 2022-01-14
- 2022-03-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-09 | Pfizer-BioNTech | No |
| 2 | 2021-12-03 | Pfizer-BioNTech | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.